Inoca International
Dec 14, 2025, 12:49
Predicting Thrombosis and Bleeding in Cancer․ The Role of Inflammatory and Cardiac Biomarkers
Filippo Crea, European Heart Journal Editor-in-Chief, posted on X:
”Inflammatory and cardiac biomarkers help predict venous thromboembolism and bleeding risk in cancer patients. Toward smarter risk stratification.”
Read the full Article here.
Title: Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers
Authors: Danielle Carole Roy, Tzu-Fei Wang, Ranjeeta Mallick, Dylan Burger, Marc Carrier, Philip Wells, Steven Hawken
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?